Literature DB >> 20324808

Eosinophil Count and Cortisone and ACTH.

J R Martin, C J Pattee.   

Abstract

Entities:  

Year:  1953        PMID: 20324808      PMCID: PMC1822842     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  The evaluation of eosinophil-counts.

Authors:  J N SWANSON; W BAUER; M ROPES
Journal:  Lancet       Date:  1952-01-19       Impact factor: 79.321

2.  Eosinophil levels as an index of adrenal responsiveness; factors that affect value of eosinophil counts.

Authors:  C D BONNER
Journal:  J Am Med Assoc       Date:  1952-02-23

3.  Hematologic changes with ACTH and cortisone therapy of rheumatoid arthritis.

Authors:  S C FINCH; C L CROCKETT; J F ROSS; T B BAYLES
Journal:  Blood       Date:  1951-11       Impact factor: 22.113

4.  Prevention of hormona eosinopenia and lymphopenia by inhibition of clotting in blood; preliminary report.

Authors:  Z Z GODLOWSKI
Journal:  Br Med J       Date:  1951-04-21

5.  In vitro effects of cortisone on mesodermal tissue.

Authors:  G D BALDRIDGE; A M KLIGMAN; M J LIPNIK; D M PILLSBURY
Journal:  AMA Arch Pathol       Date:  1951-06

6.  The diagnostic importance of ACTH.

Authors:  J WALDENSTROM
Journal:  Acta Endocrinol (Copenh)       Date:  1950

7.  Eosinophil and other leucocyte changes in burned patients, with special reference to adreno-cortical activity.

Authors:  S SEVITT
Journal:  Br Med J       Date:  1951-05-05

8.  Effect of adreno-cortical extracts on bone marrow eosinophiles of mice.

Authors:  M L DURGIN; R K MEYER
Journal:  Endocrinology       Date:  1951-05       Impact factor: 4.736

9.  The effects of stress, adrenal and adrenocorticotrophic hormones on the circulating eosinophils of mice.

Authors:  R S SPEIRS; R K MEYER
Journal:  Endocrinology       Date:  1949-10       Impact factor: 4.736

10.  ACTH in the treatment of severe burns.

Authors:  A OLSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1952-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.